Wu Bo: The diagnosis and treatment system for patients with pulmonary hypertension is becoming more and more mature

Recently, Beijing Aisike Pulmonary Hypertension Rare Disease Care Center held its 10th anniversary commemoration activities in Guangzhou. Aisike is the only non-governmental organization registered with the civil affairs department in China to provide support and assistance to patients with pulmonary hypertension. At the scene of the event, Wu Bo, deputy director of the Department of Lung Transplantation of Wuxi People's Hospital and director of the Second Department of Respiratory and Critical Care, made a speech.

Wu Bo said: "I am very happy to accept the invitation to participate in the 10th anniversary of Aisike, I am a doctor who specializes in lung transplantation, and I have an indissoluble relationship with Aixianke, and the founders of Aixianke, Huang Huan and Li Rong, have a good relationship with us, and I am honored to be able to participate in this activity." Aisike is a bridge between patients and doctors, through lung transplantation to treat patients with pulmonary hypertension, and now gradually mature, in this regard, Aixianke has done a lot of work, from the founder Huang Huan's two lung transplants, I have a lot of profound experience. ”

Wu Bo also said: "After 10 years of efforts by Aixianke, the diagnosis and treatment system of pulmonary hypertension in China is very complete, and lung transplant surgery has gradually developed in China with these 10 years, and lung transplant surgery has gradually matured in China, especially for lung transplantation of patients with pulmonary hypertension, the current treatment of pulmonary hypertension, from drugs, surgery, lung transplantation has formed a relatively complete system." This is a new look from 10 years ago. ”

Text/Guangzhou Daily, New Flower City Reporter: Wu Wei

Photo/ Guangzhou Daily, Xinhuacheng Reporter: Wu Wei

Video/Guangzhou Daily Xinhuacheng Reporter: Wu Wei

Guangzhou Daily New Flower City Editor: Cai Lingyue